Troy Dale

CEO, CCO, Board Member, Strategic Adviser, Illuminator of dark corners

📍 Switzerland🔄 Updated September 2026💼 2 investments📅 4 years investing🗓 Last invested Jan 2024
VC🌍 Switzerland
2
Total investments
1
Early stage
0
Mid stage
0
Late stage
4y
Years active

Portfolio

2 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor and Strategic Advisor
Jan 2024
Syntropic is a clinical stage medical device company developing new technologies that enhance the brain’s neuroplasticity, allowing for the treatment of psychiatric disorders and the improvement of cognition.
Angel Investor
Jan 2022
Springboard Health Angels is a Berlin-based business angel group that invests in early-stage life sciences startups, with a focus on health tech
Experience · 5 entries
All (5)
Investments (2)
2024
Newton Fellow
Oct 2024
Newton Venture Program provides venture capital training and development for aspiring investors, practising investors, and others in the venture space. Our mission is to level the playing field for people from typically overlooked and underestimated backgrounds, ensuring that the next generation of investors represent the world we live in. Newton Alumni span the globe with more than 500 people from all backgrounds going on to secure positions in VC firms, accelerate their careers in VC, and become disruptors of the status quo. As of the start of 2024, 46% identify as female or non-binary, and 49% identify as the global majority. Newton is a joint venture between Phoenix Court and London Business School with founding partner, HSBC Innovation Banking. With our unique blend of faculty and practitioner teaching, we are training the investors of tomorrow to back the ventures of the future.
mid stageEducation
Investor and Strategic Advisor
Jan 2024
Syntropic is a clinical stage medical device company developing new technologies that enhance the brain’s neuroplasticity, allowing for the treatment of psychiatric disorders and the improvement of cognition.
2022
Business mentor
Aug 2022
Creative Destruction Lab (CDL) is a nonprofit organization that delivers an objectives-based program for massively scalable, seed-stage, science- and technology-based companies. The nine-month program employs an objectives-based mentoring process to enhance the performance of technical founders who learn from the insights of experienced entrepreneurs, with the goal of maximizing equity-value creation. Founded by Professor Ajay Agrawal in 2012 at the University of Toronto’s Rotman School of Management, the program has expanded and now has 11 sites across six countries: Toronto, Vancouver, Calgary, Montreal, Halifax, Paris, Madison, Seattle, Estonia, Berlin, and Melbourne. The program combines 5 elements to help companies transition from science projects to scalable and financeable companies: - An emphasis on objective-setting, helping companies focus on what’s most important to their business - Focused mentorship from experienced entrepreneurs who have founded, led, and sold significant tech companies - Technical advice from world-leading scientists, engineers, and economists - Hands-on support from top business students, who embed within the company to provide business support - Opportunities to raise capital, including angels and VCs from Europe and North America The successful commercialization of cutting-edge science and technology achieved through the program has led to the creation of over CAD $35 billion in equity value.
Angel Investor
Jan 2022
Springboard Health Angels is a Berlin-based business angel group that invests in early-stage life sciences startups, with a focus on health tech
2014
Head Commercial - Strategic Partnerships Unit (Vice President)
May 2014
Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Find out more at https://www.novartis.com See our community guidelines: https://go.novartis.social/3Nboxki